Perrigo Vitamin Sales Jump 20%, OTCs Up 13% In Fiscal First Quarter
This article was originally published in The Tan Sheet
Perrigo's vitamin and supplement sales posted double-digit gains in the fiscal first quarter ended Sept. 29, fueled primarily by letter vitamins and glucosamine/ chondroitin supplements, the firm announced Oct. 23.
You may also be interested in...
Corrective actions taken in response to an unfavorable FDA inspection of Perrigo's Allegan, Mich. facility will preclude the planned November launch of minoxidil 5% and stall the company's pipeline, Perrigo told analysts in an Oct. 25 conference call.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Combe sells most of its OTC brands